Trial Profile
Phase II study of intravenous and intraperitoneal paclitaxel combined with S-1 for gastric cancer with peritoneal metastasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jun 2011
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 15 Jun 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network Japan record.
- 15 Dec 2009 New trial record